ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
3.1K
|
774K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
1 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
3.1K
|
774K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
jrw7
|
1.0K |
399K |
25 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
25
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
3 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
3.1K
|
774K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
3 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
3.1K
|
774K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
4 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
3.1K
|
774K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
1 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
3.1K
|
774K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
4 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
3.1K
|
774K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
6 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
3.1K
|
774K
|
6
|
|
ASX - By Stock
|
WBT |
Re:
Ann: WBT's ReRAM IP now fully qualified in SkyWater S130 process
|
|
jrw7
|
388 |
153K |
15 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
388
|
153K
|
15
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Change of Director's Interest Notices
|
|
jrw7
|
22 |
8.7K |
9 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
22
|
8.7K
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Change of Director's Interest Notices
|
|
jrw7
|
22 |
8.7K |
3 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
22
|
8.7K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
jrw7
|
8.2K |
3.2M |
1 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
8.2K
|
3.2M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
jrw7
|
8.2K |
3.2M |
15 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
8.2K
|
3.2M
|
15
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2023 and beyond
|
|
jrw7
|
2.9K |
1.4M |
23 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
2.9K
|
1.4M
|
23
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Response to ASX Price Query
|
|
jrw7
|
77 |
33K |
46 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
77
|
33K
|
46
|
|
ASX - By Stock
|
WBT |
Re:
Wow what just happened?
|
|
jrw7
|
63 |
30K |
5 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
63
|
30K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
jrw7
|
3.1K |
774K |
3 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
3.1K
|
774K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Notice Of General Meeting
|
|
jrw7
|
4 |
1.7K |
7 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
4
|
1.7K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Instituational Buying of WBT is Now Allowed
|
|
jrw7
|
36 |
16K |
3 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
36
|
16K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Instituational Buying of WBT is Now Allowed
|
|
jrw7
|
36 |
16K |
1 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
36
|
16K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
jrw7
|
8.2K |
3.2M |
35 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
8.2K
|
3.2M
|
35
|
|
ASX - By Stock
|
WBT |
Re:
Ann: First Weebit ReRAM product now available through SkyWater
|
|
jrw7
|
64 |
39K |
22 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
64
|
39K
|
22
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Appendix 4D and Interim Report
|
|
jrw7
|
69 |
31K |
29 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
69
|
31K
|
29
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Trading Halt
|
|
jrw7
|
205 |
106K |
22 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
205
|
106K
|
22
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2023 and beyond
|
|
jrw7
|
2.9K |
1.4M |
7 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
2.9K
|
1.4M
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
jrw7
|
2.9K |
1.3M |
3 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit presentation on technical and commercial progress
|
|
jrw7
|
147 |
75K |
10 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
147
|
75K
|
10
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit presentation on technical and commercial progress
|
|
jrw7
|
147 |
75K |
14 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
147
|
75K
|
14
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano successfully qualifies its ReRAM module
|
|
jrw7
|
160 |
91K |
22 |
30/10/22 |
30/10/22 |
ASX - By Stock
|
160
|
91K
|
22
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
jrw7
|
240 |
112K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
240
|
112K
|
2
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano successfully qualifies its ReRAM module
|
|
jrw7
|
160 |
91K |
35 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
160
|
91K
|
35
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Registered Office Address Change
|
|
jrw7
|
14 |
8.1K |
18 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
14
|
8.1K
|
18
|
|
ASX - By Stock
|
BRN |
Re:
4C Estimate - Receipts and Cash Outflow
|
|
jrw7
|
8 |
5.4K |
4 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
8
|
5.4K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes EQE
|
|
jrw7
|
112 |
41K |
2 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
112
|
41K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes EQE
|
|
jrw7
|
112 |
41K |
2 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
112
|
41K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
4 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
10K
|
4.8M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
4 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
10K
|
4.8M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
9 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
10K
|
4.8M
|
9
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
7 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
10K
|
4.8M
|
7
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
8 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
10K
|
4.8M
|
8
|
|
ASX - By Stock
|
BRN |
Re:
New IPhone 14 Could this be Akida.
|
|
jrw7
|
30 |
14K |
11 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
30
|
14K
|
11
|
|
ASX - By Stock
|
BRN |
Re:
Competitive landscape
|
|
jrw7
|
3.8K |
1.4M |
16 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
3.8K
|
1.4M
|
16
|
|
ASX - By Stock
|
BRN |
Re:
brn nviso
|
|
jrw7
|
21 |
10K |
8 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
21
|
10K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
0 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
10K
|
4.8M
|
0
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
8 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
10K
|
4.8M
|
8
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
3 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
10K
|
4.8M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
Brainchip heading into buyout territory
|
|
jrw7
|
12 |
6.5K |
5 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
12
|
6.5K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
6 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
10K
|
4.8M
|
6
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
jrw7
|
10K |
4.8M |
12 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
10K
|
4.8M
|
12
|
|